Mobile

Clinical Trial to Assess the Safety and Efficacy of Aztreonam for Inhalation Solution (AZLI) in patients with Cystic Fibrosis (CF) and Chronic Burkholderia Species Infection

Update Il y a 4 ans
Reference: EUCTR2009-011740-19

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective is to evaluate the safety and efficacy of continuous AZLI treatment in subjects with CF and Burkholderia spp. infection in the airways.

Inclusion criteria

  • Cystic Fibrosis subjects with chronic Burkholderia spp. infection of the airways

Links